BridgeMD
New treatment option for Major Depressive Disorder
Official title Treating Loneliness In The Older Adult With Depression With tDCS
ClinicalTrials.gov ID: NCT06658795
What this study is testing
- What it's testing
- High loneliness is prevalent among older adults and is a significant risk factor for major depression and low recovery rates in patients. Current interventions for loneliness are limited.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 80. Healthy volunteers may be eligible.
You may be able to join if
- High loneliness (UCLA Loneliness Scale \> 43).
- Diagnosis of major depressive disorder confirmed by the Structured Clinical Interview for DSM-5 Disorders.
- absence of suicidal ideation (Hamilton Depression Scale item 3 score ≤ 1).
You likely can't join if
- Severe neurological diseases.
- Bipolar disorder, schizophrenia, addiction, or impulse control disorders.
- Contraindications for tDCS or MRI (e.g., metal implants).
- Presence of suicidal ideation.
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.